Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)

Clinical trial NCT06228066 · RECRUITING

Trial details

NCT number: NCT06228066
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Carcinoma of the Bladder High Grade Neuroendocrine Tumors of the Urinary Tract

Start date: 2024-06-13
Primary completion: 2027-09-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.